Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,737822,Alc10,Alcohol consumption QTL 10,2.2,,consumption behavior trait (VT:0002069),ethanol drink intake rate (CMO:0001407),12,22650702,45946937,Rat,n/a,region,qtl 1000,1641928,Alcrsp5,Alcohol response QTL 5,,,response to alcohol trait (VT:0010489),duration of loss of righting reflex (CMO:0002289),12,18342477,52716770,Rat,n/a,region,qtl 1000,634350,Apr4,Acute phase response QTL 4,6,,orosomucoid 1 amount (VT:0010541),plasma orosomucoid 1 level (CMO:0001467),12,4210051,49210051,Rat,n/a,region,qtl 1000,634351,Apr5,Acute phase response QTL 5,6.7,,blood interleukin-6 amount (VT:0008595),plasma interleukin-6 level (CMO:0001927),12,2513442,47513442,Rat,n/a,region,qtl 1000,2293684,Bmd26,Bone mineral density QTL 26,4.4,0.0002,femur mineral mass (VT:0010011),total volumetric bone mineral density (CMO:0001728),12,17960865,38409001,Rat,n/a,region,qtl 1000,2300186,Bmd59,Bone mineral density QTL 59,7.1,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),12,15908900,52716770,Rat,n/a,region,qtl 1000,1331761,Bp218,Blood pressure QTL 218,2.973,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),12,13127211,50320041,Rat,n/a,region,qtl 1000,1331755,Bp219,Blood pressure QTL 219,3.041,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),12,13127211,31723688,Rat,n/a,region,qtl 1000,1549912,Bp268,Blood pressure QTL 268,,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),10,18752593,52716770,Rat,n/a,region,qtl 1000,1549902,Bp269,Blood pressure QTL 269,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,18752593,52716770,Rat,n/a,region,qtl 1000,1598855,Bp294,Blood pressure QTL 294,3.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,1,36919844,Rat,n/a,region,qtl 1000,631543,Bp83,Blood pressure QTL 83,5.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),12,17185580,44098244,Rat,n/a,region,qtl 1000,2293699,Bss49,Bone structure and strength QTL 49,5.61,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra trabecular cross-sectional area (CMO:0001692),12,15908900,52716770,Rat,n/a,region,qtl 1000,61443,Btemp2,Thermal response to stress QTL 2,3.3,,body temperature trait (VT:0005535),core body temperature (CMO:0001036),12,17114770,23839390,Rat,n/a,region,qtl 1000,6893681,Bw109,Body weight QTL 109,2.3,0.004,body mass (VT:0001259),body weight (CMO:0000012),12,1,23758197,Rat,n/a,region,qtl 1000,61404,Bw120,Body weight QTL 120,5.1,,body mass (VT:0001259),body mass index (BMI) (CMO:0000105),12,14419775,52716770,Rat,n/a,region,qtl 1000,7411545,Bw128,Body weight QTL 128,5.2,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,7411547,Bw129,Body weight QTL 129,,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),6,9223626,52716770,Rat,n/a,region,qtl 1000,8694179,Bw150,Body weight QTL 150,2.9,0.001,body mass (VT:0001259),body weight gain (CMO:0000420),12,150810,45150810,Rat,n/a,region,qtl 1000,61421,Cia12,Collagen induced arthritis QTL 12,4.6,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,15714609,41291738,Rat,n/a,region,qtl 1000,1298081,Cia25,Collagen induced arthritis QTL 25,4.7,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,22650721,41291738,Rat,n/a,region,qtl 1000,1581516,Cm56,Cardiac mass QTL 56,4.2,0.05,heart left ventricle mass (VT:0007031),heart left ventricle weight to body weight ratio (CMO:0000530),12,1,30749723,Rat,n/a,region,qtl 1000,10755457,Coatc14,Coat color QTL 14,,0.01759,coat/hair pigmentation trait (VT:0010463),pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812),12,1,23035872,Rat,n/a,region,qtl 1000,61324,Eae5,Experimental allergic encephalomyelitis QTL 5,14,,nervous system integrity trait (VT:0010566),percentage of study population developing relapsing-remitting experimental autoimmune encephalomyelitis during a period of time (CMO:0001402),12,22650702,52716770,Rat,n/a,region,qtl 1000,2306789,Ean6,Experimental allergic neuritis QTL 6,4.9,,nervous system integrity trait (VT:0010566),experimental autoimmune neuritis severity score (CMO:0001528),12,22650702,27190240,Rat,n/a,region,qtl 1000,61331,Eau2,Experimental allergic uveoretinitis QTL 2,,0.0005,uvea integrity trait (VT:0010551),experimental autoimmune uveitis score (CMO:0001504),12,10256890,31723732,Rat,n/a,region,qtl 1000,7411597,Foco10,Food consumption QTL 10,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411641,Foco19,Food consumption QTL 19,27.7,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411660,Foco28,Food consumption QTL 28,10.9,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411586,Foco5,Food consumption QTL 5,5.4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,7411588,Foco6,Food consumption QTL 6,,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,9223626,52716770,Rat,n/a,region,qtl 1000,7411595,Foco9,Food consumption QTL 9,4,0.001,eating behavior trait (VT:0001431),feed conversion ratio (CMO:0001312),12,150810,45150810,Rat,n/a,region,qtl 1000,2303569,Gluco44,Glucose level QTL 44,2,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),12,18342477,52716770,Rat,n/a,region,qtl 1000,2293086,Iddm30,Insulin dependent diabetes mellitus QTL 30,3.82,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),12,10175889,31975590,Rat,n/a,region,qtl 1000,9590086,Insglur6,Insulin/glucose ratio QTL 6,18.97,0.001,blood insulin amount (VT:0001560),calculated plasma insulin level (CMO:0002170),12,150810,45150810,Rat,n/a,region,qtl 1000,2303575,Insul14,Insulin level QTL 14,4,,blood insulin amount (VT:0001560),blood insulin level (CMO:0000349),12,492578,45492578,Rat,n/a,region,qtl 1000,1331786,Kidm11,Kidney mass QTL 11,3.571,,kidney mass (VT:0002707),right kidney wet weight (CMO:0000082),12,13127211,27285590,Rat,n/a,region,qtl 1000,7387292,Kidm42,Kidney mass QTL 42,3.03,0.0004,kidney mass (VT:0002707),left kidney wet weight (CMO:0000083),12,1,38334225,Rat,n/a,region,qtl 1000,10059594,Kidm46,Kidney mass QTL 46,3.79,0.025,kidney mass (VT:0002707),both kidneys wet weight as percentage of body weight (CMO:0000140),12,9789834,52716770,Rat,n/a,region,qtl 1000,737979,Pia22,Pristane induced arthritis QTL 22,53.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,2475687,47475687,Rat,n/a,region,qtl 1000,2302060,Pia37,Pristane induced arthritis QTL 37,6.1,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),12,18729043,52716770,Rat,n/a,region,qtl 1000,2302042,Pia38,Pristane induced arthritis QTL 38,3.5,0.001,blood immunoglobulin amount (VT:0002460),serum immunoglobulin G1 level (CMO:0002115),12,2513442,47513442,Rat,n/a,region,qtl 1000,61416,Pia4,Pristane induced arthritis QTL 4,8.4,,joint integrity trait (VT:0010548),arthritic paw count (CMO:0001460),12,15714609,35964508,Rat,n/a,region,qtl 1000,5684888,Pia42,Pristane induced arthritis QTL 42,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),12,22650702,48598906,Rat,n/a,region,qtl 1000,8552964,Pigfal17,Plasma insulin-like growth factor 1 level QTL 17,3.5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,8552912,Pigfal6,Plasma insulin-like growth factor 1 level QTL 6,5,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223630,52716770,Rat,n/a,region,qtl 1000,8552918,Pigfal7,Plasma insulin-like growth factor 1 level QTL 7,,,blood insulin-like growth factor amount (VT:0010479),plasma insulin-like growth factor 1 level (CMO:0001299),12,9223626,52716770,Rat,n/a,region,qtl 1000,1300157,Rf21,Renal function QTL 21,4.4,,renal blood flow trait (VT:2000006),absolute change in renal blood flow rate (CMO:0001168),12,11764995,37522089,Rat,n/a,region,qtl 1000,1302792,Scl21,Serum cholesterol level QTL 21,3.8,0.0011,blood cholesterol amount (VT:0000180),plasma total cholesterol level (CMO:0000585),12,8954593,27911196,Rat,n/a,region,qtl 1000,1549829,Scl48,Serum cholesterol level QTL 48,5,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),12,15021986,52716770,Rat,n/a,region,qtl 1000,9590147,Scort7,Serum corticosterone level QTL 7,13.61,0.001,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),12,150810,45150810,Rat,n/a,region,qtl 1000,10450854,Stl34,Serum triglyceride level QTL 34,3.5,0.05,blood LDL triglyceride amount (VT:0010699),blood lipoprotein triglyceride level (CMO:0002685),12,1,22853017,Rat,n/a,region,qtl